Cargando…
Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production
Attenuated Salmonella typhimurium was selected as a transgenic vehicle for the development of live mucosal vaccines against transmissible gastroenteritis virus (TGEV). A 2.2 kb DNA fragment, encoding for N-terminal domain glycoprotein S of TGEV, was amplified by RT-PCR and cloned into eukaryotic exp...
Autores principales: | Yang, Heng, Cao, Sanjie, Huang, Xiaobo, Liu, Jiawen, Tang, Ying, Wen, Xintian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126841/ https://www.ncbi.nlm.nih.gov/pubmed/19573642 http://dx.doi.org/10.1016/j.vaccine.2009.06.050 |
Ejemplares similares
-
Immunogenicity of transmissible gastroenteritis virus (TGEV) M gene delivered by attenuated Salmonella typhimurium in mice
por: Qing, Ying, et al.
Publicado: (2016) -
Prevalence of antibodies against transmissible gastroenteritis virus (TGEV) in Hungary
por: Valkó, Anna, et al.
Publicado: (2018) -
Induction of Antibodies Protecting against Transmissible Gastroenteritis Coronavirus (TGEV) by Recombinant Adenovirus Expressing TGEV Spike Protein
por: TORRES, JUAN M., et al.
Publicado: (1995) -
Evolution of Transmissible Gastroenteritis Virus (TGEV): A Codon Usage Perspective
por: Cheng, Saipeng, et al.
Publicado: (2020) -
A competitive inhibition ELISA for the differentiation of serum antibodies from pigs infected with transmissible gastroenteritis virus (TGEV) or with the TGEV-related porcine respiratory coronavirus
por: Callebaut, P., et al.
Publicado: (1989)